drugset / Trial / NCT06715683
A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
This is a trial to evaluate the comparative bioavailability of BMS-986278 to-be-marketed formulation compared to the phase 3 clinical trial formulation in healthy participants.
Timeline
- Start
- 2024-12-12
- Primary completion
- 2025-03-16
- Completion
- 2025-03-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Admilparant | Small molecule | — | — |
Indications
No indication recorded.